Post-approval studies (Phase 4)Ended earlyNCT00436124What this trial is testingTamiflu (Oseltamivir) Treatment in Laboratory-Confirmed Influenza.Who this might be right forInfluenza Hoffmann-La Roche
Not applicableWithdrawnNCT06163677What this trial is testingLook at the Health Outcomes of Patients With COVID-19 and Influenza.Who this might be right forCOVID-19Coronavirus Disease 2019Influenza Pfizer
Not applicableStudy completedNCT01683630What this trial is testingComparison of Epidemiology and Clinical Outcomes of Influenza A & B Cases in Manitoba, CanadaWho this might be right forInfluenza International Centre for Infectious Diseases, Canada 1,849
Large-scale testing (Phase 3)Study completedNCT01319955What this trial is testingFlu Vaccine Against Childhood Pneumonia, BangladeshWho this might be right forPneumoniaLaboratory Confirmed Influenza International Centre for Diarrhoeal Disease Research, Bangladesh 3,508
Testing effectiveness (Phase 2)Study completedNCT01037205What this trial is testingRandomized, Double-blind, Placebo Controlled Phase II Study to Examine the Effects of DAS181 in Healthy Adult Subjects With Laboratory Confirmed InfluenzaWho this might be right forInfluenza Ansun Biopharma, Inc. 264
Not applicableLooking for participantsNCT06029933What this trial is testingFluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 YearsWho this might be right forInfluenzaCommunity-acquired PneumoniaCardiovascular Events Kaiser Permanente 1,500,000
Post-approval studies (Phase 4)Study completedNCT01693380What this trial is testingEffectiveness Assessment of Vaccinating Schoolchildren Against InfluenzaWho this might be right forInfluenzaAcute Respiratory Infection Butantan Institute 1,742